Agency for Healthcare Research and Quality, 61362-61363 [2013-24178]
Download as PDF
<![CDATA[
61362
Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
initiatives designed to improve the
effectiveness of federal government
operations. The meeting will also cover
planning and logistics for PMAB during
the coming year.
Meeting Access: The teleconference
meeting is open to the public; interested
members of the public may listen to the
PMAB discussion using 1–888–673–
9806 and pass code 7836092. Members
of the public will not have the
opportunity to ask questions or
otherwise participate in the
teleconference. However, members of
the public wishing to comment should
follow the steps detailed in Procedures
for Providing Public Comments below.
Availability of Materials for the
Meeting: Please see the PMAB Web site
(https://www.whitehouse.gov/
administration/advisory-boards/pmab)
for any materials available in advance of
the meeting and for meeting minutes
that will be made available after the
meeting. Detailed meeting minutes will
be posted within 90 days of the meeting.
Procedures for Providing Public
Comments: In general, public statements
will be posted on the PMAB Web site
(see above). Non-electronic documents
will be made available for public
inspection and copying in PMAB offices
at GSA, 1800 F Street NW., Washington,
DC 20006, on official business days
between the hours of 10 a.m. and 5 p.m.
eastern time. You can make an
appointment to inspect statements by
telephoning 202–501–1398. All
statements, including attachments and
other supporting materials, received are
part of the public record and subject to
public disclosure. Any statements
submitted in connection with the PMAB
meeting will be made available to the
public under the provisions of the
Federal Advisory Committee Act
(FACA).
The public is invited to submit
written statements for this meeting until
12:30 p.m. eastern time on Friday,
October 18, 2013, by either of the
following methods: Electronic or Paper
Statements: Submit electronic
statements to Mr. Brockelman,
Designated Federal Officer at
stephen.brockelman@gsa.gov; or send
paper statements in triplicate to Mr.
Brockelman at the PMAB GSA address
above.
Dated: September 27, 2013.
Anne Rung,
Associate Administrator, Office of
Government-wide Policy, General Services
Administration.
[FR Doc. 2013–24145 Filed 10–2–13; 8:45 am]
BILLING CODE 6820–BR–P
VerDate Mar<15>2010
18:29 Oct 02, 2013
Jkt 232001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Council on Alzheimer’s
Research, Care, and Services; Meeting
Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). The
Advisory Council on Alzheimer’s
Research, Care, and Services provides
advice on how to prevent or reduce the
burden of Alzheimer’s disease and
related dementias on people with the
disease and their caregivers. During the
October meeting, the Advisory Council
will welcome new members and discuss
the timeline for the 2014
recommendations. The subcommittees
will discuss priorities and areas for
recommendations. The Advisory
Council will hear presentations on work
underway to harness ‘‘big data’’ to
address Alzheimer’s research.
DATES: The meeting will be held on
October 28, 2013 from 9:00 a.m. to 5:00
p.m. EDT.
ADDRESSES: The meeting will be held in
the Great Hall of the U.S. Department of
Health and Human Services, 200
Independence Avenue SW.,
Washington, DC 20201.
Comments: Time is allocated on the
agenda to hear public comments. In lieu
of oral comments, formal written
comments may be submitted for the
record to Helen Lamont, Ph.D., OASPE,
200 Independence Avenue SW., Room
424E, Washington, DC 20201.
Comments may also be sent to napa@
hhs.gov. Those submitting written
comments should identify themselves
and any relevant organizational
affiliations.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Helen Lamont, Ph.D. (202) 690–7996,
helen.lamont@hhs.gov. Note: Seating
may be limited. Those wishing to attend
the meeting must send an email to
napa@hhs.gov and put ‘‘October 28
meeting attendance’’ in the Subject line
by Friday, October 18, 2013, so that
their names may be put on a list of
expected attendees and forwarded to the
security officers at the Department of
Health and Human Services. Any
interested member of the public who is
a non-U.S. citizen should include this
information at the time of registration to
ensure that the appropriate security
procedure to gain entry to the building
is carried out. Although the meeting is
open to the public, procedures
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
governing security and the entrance to
Federal buildings may change without
notice. If you wish to make a public
comment, you must note that within
your email.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is given under the
Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)(1) and
(a)(2)). Topics of the Meeting: The
Advisory Council will welcome new
members and discuss the timeline for
the 2014 recommendations. The
subcommittees will discuss priorities
and areas for recommendations. The
Advisory Council will hear
presentations on work underway to
harness ‘‘big data’’ to address
Alzheimer’s research.
Procedure and Agenda: This meeting
is open to the public.
Authority: 42 U.S.C. 11225; Section 2(e)(3)
of the National Alzheimer’s Project Act. The
panel is governed by provisions of Public
Law 92–463, as amended (5 U.S.C. Appendix
2), which sets forth standards for the
formation and use of advisory committees.
Dated: October 1, 2013.
Donald Moulds,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2013–24206 Filed 10–2–13; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meetings
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Five AHRQ
Subcommittee Meetings.
AGENCY:
The subcommittees listed
below are part of AHRQ’s Health
Services Research Initial Review Group
Committee. Grant applications are to be
reviewed and discussed at these
meetings. Each subcommittee meeting
will commence in open session before
closing to the public for the duration of
the meeting. These meetings will be
closed to the public in accordance with
5 U.S.C. App. 2 section 10(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6).
DATES: See below for dates of meetings:
1. Healthcare Effectiveness and
Outcomes Research (HEOR)
Date: October 16, 2013 (Open from
8:00 a.m. to 8:30 a.m. on October 16
and closed for remainder of the
meeting)
2. Health System and Value Research
(HSVR)
SUMMARY:
E:\FR\FM\03OCN1.SGM
03OCN1
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices
Date: October 16, 2013 (Open from
8:00 a.m. to 8:30 a.m. on October 16
and closed for remainder of the
meeting)
3. Health Care Research and Training
(HCRT)
Date: October 17–18, 2013 (Open from
8:00 a.m. to 8:30 a.m. on on October
17 and closed for remainder of the
meeting)
4. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: October 23–24, 2013 (Open from
8:00 a.m. to 8:30 a.m. on October 23
and closed for remainder of the
meeting)
5. Healthcare Information Technology
Research (HITR)
Date: October 31—November 1, 2013
(Open from 8:00 a.m. to 8:30 a.m.
on October 31 and closed for
remainder of the meeting)
ADDRESSESS: The five meetings will take
place at the following location: Hyatt
Regency Hotel Bethesda, One Metro
Center, Bethesda, MD 20814.
FOR FURTHER INFORMATION CONTACT: (To
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meetings.) Mrs. Bonnie Campbell,
Committee Management Officer, Office
of Extramural Research Education and
Priority Populations, AHRQ, 540
Gaither Road, Suite 2000, Rockville,
Maryland 20850, Telephone (301) 427–
1554.
SUPPLEMENTARY INFORMATION: In
accordance with section 10(a)(2) of the
Federal Advisory Committee Act
(5 U.S.C. App. 2), AHRQ announces
meetings of the scientific peer review
groups listed above, which are
subcommittees of AHRQ’s Health
Services Research Initial Review Group
Committee. Each subcommittee meeting
will commence in open session before
closing to the public for the duration of
the meeting. The subcommittee
meetings will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2 section 10(d),
5 U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6) The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for these meetings are
subject to change as priorities dictate.
Dated: September 25, 2013.
Richard Kronick,
Director.
[FR Doc. 2013–24178 Filed 10–2–13; 8:45 am]
BILLING CODE 4160–90–P
VerDate Mar<15>2010
18:29 Oct 02, 2013
Jkt 232001
61363
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
be received within 60 days of this
notice.
Agency for Healthcare Research and
Quality
Proposed Project
Correction—Scientific Information
Request on Medication Therapy
Management
The original date of publication for
this Federal Register notice was
September 17, 2013, 78 FR 57159. On
this publication, the Web site that
appears under ADDRESSES is incorrect in
page 57159. The correct Web site is:
https://effectivehealthcare.AHRQ.gov/
index.cfm/submit-scientificinformation-packets/
Dated: September 27, 2013.
Richard Kronick,
AHRQ Director.
[FR Doc. 2013–24182 Filed 10–2–13; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–13–0787]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, at CDC
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to omb@
cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Personal Flotation Devices (PFDs) and
Commercial Fishermen: Preconceptions
and Evaluation in Actual Use—
Reinstatement with Change—(OMB
Number 0920–0787, expiration date 8/
31/2010) National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
NIOSH has the responsibility under
Pub. L. 91–596 section 20 (Occupational
Safety and Health Act of 1970) to
conduct research relating to innovative
methods, techniques, and approaches
for dealing with occupational safety and
health problems.
Commercial fishing is one of the most
dangerous occupations in the United
States, with a fatality rate 30 times
higher than the national average. Most
fishermen who die on the job drown
subsequent to a vessel sinking (52%) or
fall overboard (31%). Because drowning
is the leading cause of death for
commercial fishermen, its prevention is
one of the highest priorities for those
who work to make the industry safer.
The risk of drowning for commercial
fisherman is high, yet most fishermen
do not wear Personal Flotation Devices
(PFDs) while on deck. Of the 182
fishermen who died from falls
overboard between 2000 and 2011 none
of them were wearing a personal
flotation device (PFD). Many were
within minutes of being rescued when
they lost their strength and disappeared
under the surface of the water.
NIOSH recently conducted a study to
establish a baseline understanding of
Alaska fishermen’s perceptions of risk,
safety attitudes, and beliefs about PFDs;
and to evaluate a variety of modern
PFDs with commercial fishermen to
discover the features and qualities that
they like and dislike. Based upon these
results, NIOSH developed an intensive
risk communication strategy to raise
awareness to newer (potentially more
satisfactory) PFD models, to address
barriers, and to encourage increased
PFD use among fishermen working in
Alaska.
The purpose of this study is to first,
determine if fishermen’s perception of
risk, safety attitudes, and beliefs about
PFDs has shifted or remained the same
since the implementation of the initial
survey (2008–2009); and second, to
evaluate the effectiveness of the NIOSH
intensive risk communication
intervention.
E:\FR\FM\03OCN1.SGM
03OCN1
]]>Agencies
[Federal Register Volume 78, Number 192 (Thursday, October 3, 2013)]
[Notices]
[Pages 61362-61363]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24178]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meetings
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of Five AHRQ Subcommittee Meetings.
-----------------------------------------------------------------------
SUMMARY: The subcommittees listed below are part of AHRQ's Health
Services Research Initial Review Group Committee. Grant applications
are to be reviewed and discussed at these meetings. Each subcommittee
meeting will commence in open session before closing to the public for
the duration of the meeting. These meetings will be closed to the
public in accordance with 5 U.S.C. App. 2 section 10(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6).
DATES: See below for dates of meetings:
1. Healthcare Effectiveness and Outcomes Research (HEOR)
Date: October 16, 2013 (Open from 8:00 a.m. to 8:30 a.m. on October
16 and closed for remainder of the meeting)
2. Health System and Value Research (HSVR)
[[Page 61363]]
Date: October 16, 2013 (Open from 8:00 a.m. to 8:30 a.m. on October
16 and closed for remainder of the meeting)
3. Health Care Research and Training (HCRT)
Date: October 17-18, 2013 (Open from 8:00 a.m. to 8:30 a.m. on on
October 17 and closed for remainder of the meeting)
4. Healthcare Safety and Quality Improvement Research (HSQR)
Date: October 23-24, 2013 (Open from 8:00 a.m. to 8:30 a.m. on
October 23 and closed for remainder of the meeting)
5. Healthcare Information Technology Research (HITR)
Date: October 31--November 1, 2013 (Open from 8:00 a.m. to 8:30
a.m. on October 31 and closed for remainder of the meeting)
ADDRESSESS: The five meetings will take place at the following
location: Hyatt Regency Hotel Bethesda, One Metro Center, Bethesda, MD
20814.
FOR FURTHER INFORMATION CONTACT: (To obtain a roster of members, agenda
or minutes of the non-confidential portions of the meetings.) Mrs.
Bonnie Campbell, Committee Management Officer, Office of Extramural
Research Education and Priority Populations, AHRQ, 540 Gaither Road,
Suite 2000, Rockville, Maryland 20850, Telephone (301) 427-1554.
SUPPLEMENTARY INFORMATION: In accordance with section 10(a)(2) of the
Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces
meetings of the scientific peer review groups listed above, which are
subcommittees of AHRQ's Health Services Research Initial Review Group
Committee. Each subcommittee meeting will commence in open session
before closing to the public for the duration of the meeting. The
subcommittee meetings will be closed to the public in accordance with
the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C.
552b(c)(4), and 5 U.S.C. 552b(c)(6) The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Agenda items for these meetings are subject to change as priorities
dictate.
Dated: September 25, 2013.
Richard Kronick,
Director.
[FR Doc. 2013-24178 Filed 10-2-13; 8:45 am]
BILLING CODE 4160-90-P
